| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
The National Center of Oncology, Academy of Medicine, Plovdivsko pole 6, Sofia-56/Darvenitza, Bulgaria
There are very few proliferating cells in the thyroid gland of normal adult rats, as measured by the labeling and mitotic index. One-tenth % 4-methyl-2-thiouracil in drinking water induced an exponential increase of thyroid weight after a lag phase of 2 days; the increase continued for 8 days and was followed by a plateau phase. The following sequence of events was found for the number of dividing follicular and stroma cells as well as for DNA synthesis: no significant changes during the 1st 2 days, a sharp increase between the 2nd and 8th days, a decrease between the 8th and 14th days, and an almost constant flow until the 24th day. Three-hundred rads of X-rays given to a nonproliferating thyroid gland induced tumor growth in 25% of the animals 18 months after irradiation. The same dose of irradiation, applied to a proliferating thyroid gland, increased the tumor incidence to 30% when administered in the lag phase, to 75% when administered at the peak of the proliferating phase, and to 62.5% when administered at the plateau phase. Subsequent treatment of irradiated animals with 4-methyl-2-thiouracil enhanced the number and the size of the thyroid tumors and lead to the occurrence of more carcinomas than appeared in animals treated with X-rays only or 4-methyl-2-thiouracil only.
1 Part of this work was presented at the Sixth Meeting of the European Study Group for Cell Proliferation, Moscow, U.S.S.R., September 25 to 29, 1973. Supported by a grant from the International Agency for Research on Cancer, Lyon, France.
2 The author carried out this work at the Department of Pathology, University of Freiburg, Freiburg, West Germany, while on leave from the National Center of Oncology, Sofia, Bulgaria.
Received 9/10/74. Accepted 1/22/75.
This article has been cited by other articles:
![]() |
A. T. Meadows Second Malignant Neoplasms in Childhood Cancer Survivors Journal of Pediatric Oncology Nursing, January 1, 1989; 6(1): 7 - 11. [PDF] |
||||
![]() |
H. Goldschmidt, R. O. Gorson, and M. Lassen Dermatologic Radiotherapy and Thyroid Cancer: Dose Measurements and Risk Quantification Arch Dermatol, May 1, 1983; 119(5): 383 - 390. [Abstract] [PDF] |
||||
![]() |
F. S. Greenspan Radiation Exposure and Thyroid Cancer JAMA, May 9, 1977; 237(19): 2089 - 2091. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |